GALT vs ROST · $142.4M cap vs P/E 21, rev $22.75B
Galectin Therapeutics Inc (GALT) versus Ross Stores Inc (ROST) — a side-by-side from cached financials, not a winner call.
Galectin Therapeutics Inc (GALT) is a biotechnology company listed on US.
Ross Stores Inc (ROST) is a apparel retail company listed on US.
GALT does not have a complete income-statement cache yet.
Latest reported ROST revenue for 2026-01-31 was $22.75B. Net income was $2.15B. Revenue was up 7.7% from 2025-02-01 to 2026-01-31. ROST currently screens at market cap $43.03B and trailing P/E 20.8.
GALT currently screens at market cap $142.4M. ROST currently screens at market cap $43.03B and trailing P/E 20.8.
Not investment advice. Open the GALT and ROST stock pages for the full models.
Not investment advice.